Internal Medicine, Hematology · New Haven, CT
NPI
1891731667
Since 2006
Specialty
Internal Medicine, Hematology
Code 207RH0000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
333 Cedar St, Yale University School of Medicine, Hematology Division
New Haven, CT, 06510
Phone (203) 200-4363
Groups this clinician bills Medicare through
Medicare paid, 2024
$37K
529 services
Medicare patients, 2024
114
Average age 73
Drug cost, 2024
$7.5M
674 prescriptions
Company payments, 2025
$23K
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nikolai A Podoltsev was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 143 times for 77 patients. In total Nikolai A Podoltsev billed 529 services in 12 codes, and Medicare paid $37K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-01-11.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 143 | 77 | $13.27 | $1,897 |
| 99233 Hospital E&M - Subsequent | Facility | 116 | 22 | $96.42 | $11K |
| 99215 Office E&M - Established | Facility | 110 | 54 | $113.03 | $12K |
| 99214 Office E&M - Established | Facility | 44 | 34 | $67.44 | $2,968 |
| 99213 Office E&M - Established | Facility | 36 | 26 | $43.55 | $1,568 |
| 99205 Office E&M - New | Facility | 13 | 13 | $148.35 | $1,929 |
| 99223 Hospital E&M - Initial | Facility | 11 | 11 | $141.06 | $1,552 |
By year: 2022 $37K for 458 services; 2023 $38K for 432 services; 2024 $37K for 529 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nikolai A Podoltsev prescribed most often to Medicare patients was Jakafi (Ruxolitinib Phosphate), with 132 prescriptions and refills. In total Nikolai A Podoltsev wrote 674 Medicare prescriptions that cost $7.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Jakafi Ruxolitinib Phosphate | 132 | 138 | 17 | $2.3M |
| Hydroxyurea Generic | 49 | 113 | 17 | $1,096 |
| Bosulif Bosutinib | 45 | 45 | Under 11 | $634K |
| Imatinib Mesylate Generic | 40 | 40 | Under 11 | $79K |
| Ondansetron Odt Ondansetron | 38 | 40 | 19 | $839 |
| Cyclosporine Modified Cyclosporine, Modified | 34 | 35 | Under 11 | $2,071 |
| Tibsovo Ivosidenib | 25 | 25 | Under 11 | $785K |
| Ayvakit Avapritinib | 24 | 24 | Under 11 | $864K |
| Ojjaara Momelotinib Dihydrochloride | 23 | 31 | Under 11 | $830K |
| Allopurinol Generic | 18 | 18 | 11 | $85.74 |
| Scemblix Asciminib Hydrochloride | 17 | 23 | Under 11 | $631K |
| Sprycel Dasatinib | 17 | 17 | Under 11 | $106K |
| Venclexta Venetoclax | 16 | 16 | Under 11 | $105K |
| Anagrelide Hcl Generic | 14 | 22 | Under 11 | $1,164 |
| Promacta Eltrombopag Olamine | 14 | 14 | Under 11 | $414K |
Brand drugs: 376 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nikolai A Podoltsev $23K ($23K in general payments such as food, travel and fees) from 9 companies. The largest payer was Sobi, Inc with $10K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.